Specialty Vaccine Company PaxVax, Inc. Appoints Jim Connolly To Board Of Directors

PaxVax Inc., a specialty vaccine company focused on travelers and biodefense markets with a social mission to ensure global access to its vaccines, today announced the appointment of Jim Connolly to its Board of Directors. Connolly joins current Board members Rennie Coit, M.D., and Rich Tong from Ignition Capital; retired Major General Philip K. Russell, M.D.; Howie Rosen; and PaxVax Chief Executive Officer Kenneth Kelley.

Help employers find you! Check out all the jobs and post your resume.